Top Stories

Airlines are installing new luxury seats, but no one is allowed to sit in them

Lie-flat seats in private pods face long waits for safety certifications, write Alison Sider and Benjamin Katz, The Wall Street Journal.

From the ashes of Mallinckrodt, a “robust” Keenova is eyeing up a NYSE listing

It was one of the biggest restructurings in Irish corporate history with $1.3bn in debt wiped. It didn't work. It took a second insolvency, a merger and a rebrand to turnaround Keenova.

I went to a silent retreat for five days. It nearly broke my brain

A silent, no-phones retreat reveals how disorienting it can be when the mind is cut off from constant digital input, writes Pamela Paul, The Wall Street Journal.

The night the ground wouldn’t stop shaking in Venezuela

Two powerful earthquakes marked the start of a terrifying night of aftershocks, testing the country’s U.S.-backed government, write Juan Forero, Ryan Dubé and Jenny Carolina González, The Wall Street Journal.

Faith, politics and betrayal: Wallace Thompson on Jeffrey Donaldson

Following Jeffrey Donaldson's convictions, Wallace Thompson, a founding member of the DUP, speaks about his shock at the revelations, the suffering of the complainants, and what the case means for a party long shaped by evangelical Christianity.

Piers Morgan’s Uncensored funding round cements value of Brophy’s stake

Months after he sold his majority stake in Red Flag, Karl Brophy was first to invest in Morgan’s standalone production company. Big names are now joining him.

The options trader who emerged as a surprise front-runner to succeed Jamie Dimon

Troy Rohrbaugh is seen as the leading contender in a race with Doug Petno to run JPMorgan, writes Alexander Saeedy, The Wall Street Journal.

“There are businesses in this room that have lots of jobs they cannot fill; I have waiting lists”

Ireland has the lowest rate of disabled employment in the EU – businesses in the country are missing a trick if they ignore inclusive hiring.

Top Voices

From a Cork farm to the world’s largest meat company: Rewinding the week that was

Jerry O’Callaghan left religious life, travelled to India, fell in love in Brazil and eventually became chair of JBS, the $96bn food giant. He reflects on an unlikely journey and shares lessons for businesses in Ireland.

Paul Flynn: Success made Dublin feared. Struggle has made them relatable

Winning used to be routine for Dublin. Now it feels important again. Paul Flynn explains why Sunday's upset over Donegal has transformed how the team—and the public—view every result.

Succession and shadows: Brett Igoe on how Leinster should plan for life after Leo Cullen

The trophies are already secured. The lasting verdict on Cullen's reign may depend on whether Leinster can emerge from his shadow without suffering the effects of authority decay.

Dermot Desmond

Ian Kehoe: The case that outlasted the controversy

Dermot Desmond's action against The Irish Times was settled before trial this week, bringing to a close a 10-year legal battle that raises fresh questions about the length of time it takes for a defamation action to reach trial.

Full throttle: From Aer Lingus to Ryanair, airlines’ busy season spreads to the boardroom

Questions over Aer Lingus’s profitability and a hostile takeover bid for EasyJet are signs of a hot summer for an aviation industry exposed to successive geopolitical shocks.

Peter Kinsella: Goodbye Keir, hello Andy, but the UK’s challenges remain the same

As he prepares to replace Keir Starmer as British prime minister, Andy Burnham has many of the right ideas – and a very narrow economic and political path to implement them.

Intel’s stock has soared, but it needs an engineering comeback

The chip maker can get its mojo back, but it must overcome technical challenges that have dogged it in the past, writes Asa Fitch, The Wall Street Journal.

The greatest show on Earth: AI is now an asset class of its own

The series of IPOs inaugurated by SpaceX sits at the top of a mountain of capital expenditure. What happens when the laws of economics catch up with the rhetoric?